Sun To Tap Daiichi Sankyo To Sell Ranbaxy Drugs In Japan
Daiichi Sankyo, which sold Ranbaxy Laboratories to Sun Pharmaceutical Industries for $4 billion earlier this year, is about to become re-involved with the company it divested.
Daiichi Sankyo, which sold Ranbaxy Laboratories to Sun Pharmaceutical Industries for $4 billion earlier this year, is about to become re-involved with the company it divested.